NCT00004200View on ClinicalTrials.gov

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 1999

Primary Completion Date

January 31, 2002

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

prinomastat

DRUG

temozolomide

Trial Locations (1)

92037

Agouron Pharmaceuticals, Inc., La Jolla

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY